Edition:
United Kingdom

PeptiDream Inc (4587.T)

4587.T on Tokyo Stock Exchange

3,520JPY
17 Nov 2017
Change (% chg)

¥280 (+8.64%)
Prev Close
¥3,240
Open
¥3,500
Day's High
¥3,575
Day's Low
¥3,430
Volume
3,524,100
Avg. Vol
958,345
52-wk High
¥3,915
52-wk Low
¥2,450

Select another date:

Thu, Nov 16 2017

BRIEF-PeptiDream announces discovery collaboration agreement with Bayer AG

* Says it announced today that it has entered into a multi-target discovery collaboration with Germany-based Bayer AG

BRIEF- PeptiDream announces change of chairman and president

* Says it appoints current president Kiichi Kubota as chairman of the board of the company

REFILE-TABLE-Peptidream-2016/17 parent results

(Adds company forecast) Aug 9 (Reuters)- Peptidream Inc. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Jun 30, 2017 Jun 30, 2016 Jun 30, 2018 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 4.90 4.33   more than 7.00 (+13.1 pc

BRIEF-PeptiDream to set up Osaka-based special peptide drugs JV

* Says it plans to set up Osaka-based joint venture with Shionogi & Co., Ltd and Sekisui Chemical Co., Ltd. , on Sept. 1

BRIEF- Sosei Group subsidiary Heptares enters strategic collaboration with PeptiDream

* Says its unit Heptares Therapeutics and PeptiDream Inc , a public Tokyo-based biopharmaceutical company, have entered into a strategic collaboration to discover, develop and commercialise novel therapeutics targeting an undisclosed G protein-coupled receptor (GPCR) with an important role in inflammatory diseases

BRIEF- PeptiDream announces licensing of peptide discovery platform system (PDPS) technology to Shionogi

* Says it has entered into a technology license agreement with Osaka-based Shionogi & Co Ltd, to nonexclusively license PeptiDream’s proprietary Peptide discovery platform system (PDPS) technology

BRIEF-PeptiDream announces completion of technology transfer of Peptide Discovery Platform System to Lilly

* Says it completes the technology transfer of the Peptide Discovery Platform System (PDPS) to US-based Eli Lilly and Company

BRIEF-PeptiDream announces completion of technology transfer of Peptide Discovery Platform System to Genentech

* Says it completes the technology transfer of the Peptide Discovery Platform System (PDPS) to Genentech

Select another date: